Natera DPO Ratio 2011-2026 | NTRA

Annual DPO Ratio Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	17.9	32.1	22.3	30.9	23.7	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32.1	17.9	25.4

Quarterly DPO Ratio Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	17.3	18.4	-	19.6	19	25.4	33	33.7	34	27	22.1	23.2	23.1	27.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
34	17.3	24.9

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Anixa Biosciences ANIX	1.29 K	$ 3.01	-2.9 %	$ 97.7 K	USA
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Burning Rock Biotech Limited BNR	125	$ 33.99	0.65 %	$ 366 M	China
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
BioNano Genomics BNGO	104	$ 1.38	-6.12 %	$ 1.75 M	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Castle Biosciences CSTL	52	$ 39.01	-0.38 %	$ 1.08 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	106	-	-	$ 79.8 M	USA
Danaher Corporation DHR	66.4	$ 218.94	-0.24 %	$ 160 B	USA
Exact Sciences Corporation EXAS	139	$ 102.48	0.18 %	$ 19 B	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fulgent Genetics FLGT	34.9	$ 26.01	-0.88 %	$ 786 M	USA
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Guardant Health GH	83.6	$ 111.89	1.28 %	$ 13.7 B	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
DexCom DXCM	70.4	$ 73.26	-1.0 %	$ 28.3 B	USA
CareDx, Inc CDNA	44.2	$ 20.4	-1.92 %	$ 1.1 B	USA
DarioHealth Corp. DRIO	43.9	$ 10.95	6.31 %	$ 311 M	Israel
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	25.3	$ 65.82	-1.3 %	$ 4.55 B	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	56.3	$ 145.95	-2.5 %	$ 23.2 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
IQVIA Holdings IQV	126	$ 230.03	-2.31 %	$ 41.7 B	USA
NeoGenomics NEO	20.7	$ 11.85	-4.44 %	$ 1.5 B	USA
Charles River Laboratories International CRL	24.5	$ 210.0	-0.83 %	$ 10.8 B	USA
Medpace Holdings MEDP	13.3	$ 583.39	-1.63 %	$ 18.1 B	USA
Quest Diagnostics Incorporated DGX	18.3	$ 184.82	1.37 %	$ 20.5 B	USA
Personalis PSNL	67.3	$ 9.4	-5.72 %	$ 557 M	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
Precipio PRPO	53	$ 24.39	0.54 %	$ 31.7 M	USA
Laboratory Corporation of America Holdings LH	33.1	$ 269.39	-0.16 %	$ 22.6 B	USA
Mettler-Toledo International MTD	53.4	$ 1 384.16	-0.62 %	$ 29.4 B	Schweiz
ICON Public Limited Company ICLR	6.52	$ 179.07	-3.67 %	$ 14.8 B	Irlanda
IDEXX Laboratories IDXX	27	$ 674.78	-0.29 %	$ 55.6 B	USA
Agilent Technologies A	50.1	$ 132.75	-0.37 %	$ 40.4 B	USA
Biomerica BMRA	32.4	$ 2.39	0.21 %	$ 5.49 M	USA